Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Original Research

Published on 03 Apr 2025

Anticoagulation quality with warfarin therapy, and associated factors among adult outpatients at public hospitals in nekemte town, western Ethiopia: a retrospective study

in Drugs Outcomes Research and Policies

Firafan Shuma Teka
Ayana Tadesse Korsa
Habte Gebeyehu Bayisa
Dechasa Befikadu W/Senbat
Refisa Shifera Beyene
Dinka Dugassa Iticha
Birbirsa Sefera Senbeta

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1544957

306 views

Original Research

Published on 02 Apr 2025

Development and validation of a Chinese insulin medication literacy scale for patients with diabetes mellitus

in Drugs Outcomes Research and Policies

Fangying Si
Tao Feng
Xiangfen Shi
Sufang Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1477050

379 views

Original Research

Published on 02 Apr 2025

Overall compilation of adverse effects of non-steroidal anti-inflammatory drugs: a hypothesis-free systematic investigation using a nationwide cohort study

in Drugs Outcomes Research and Policies

Hyein Han
Du Hyun Ro
Hyuk-Soo Han
Sungho Won

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1539328

419 views

Policy and Practice Reviews

Accepted on 01 Apr 2025

Different routes the same destination: a comparative study of antitrust regulation for pharmaceutical industry in the United States and China

in Drugs Outcomes Research and Policies

Jie Weng
Nailiang Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1557876

Original Research

Published on 01 Apr 2025

Assessment of Gliflozins prescribing pattern in a United Arab Emirates tertiary-level care hospital

in Drugs Outcomes Research and Policies

Wessa Shenouda
Dixon Thomas
Omar Nabi
Seeba Zachariah

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1529528

502 views

Original Research

Published on 01 Apr 2025

Irisin protects against cerebral ischemia reperfusion injury in a SIRT3-dependent manner

in Drugs Outcomes Research and Policies

Yushuang Cong
Ruichun Guo
Chenglong Li
Qi Li
Sihua Qi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1558457

165 views

Original Research

Accepted on 31 Mar 2025

Optimization and Impact of an Evidence-Based Pre-Audit Prescription Decision System in Primary Healthcare Settings

in Drugs Outcomes Research and Policies

Xiao-Hui Yue
Lei Yang
Jing-Jing Zhong
Hong-Mei Liu
Dan Wang
Xue Tao
Gao-Feng Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1491810

Original Research

Published on 31 Mar 2025

Specific drugs for rare diseases in a province of eastern China under catalog management: from 2021 to 2023

in Drugs Outcomes Research and Policies

Ruifang Nie
Zhen Zhao
Yahui Zhang
Bo Xu
Wen Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1476910

311 views

Original Research

Published on 31 Mar 2025

The clinical assessment of studies on orphan drugs in relation to the EMA’s authorization marketing decisions in Europe

in Drugs Outcomes Research and Policies

Szczepan Jakubowski
Krzysztof Piotr Malinowski
Paweł Kawalec

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1558987

254 views

Systematic Review

Published on 28 Mar 2025

Factors influencing the cost-effectiveness of novel oral anticoagulants compared to vitamin K antagonists in patients with atrial fibrillation: a systematic review

in Drugs Outcomes Research and Policies

Yan Li
Xintian Wang
Aixia Ma
Pingyu Chen
Hongchao Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1441754

328 views

Original Research

Accepted on 27 Mar 2025

Off-Label Drug Use in China After the Physician Law (2021): Legal Challenges and Solutions

in Drugs Outcomes Research and Policies

Shenbao Liang
Fanxian Cai

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1547418

Original Research

Published on 26 Mar 2025

An analysis of the clinical application of paliperidone palmitate injection based on real-world

in Drugs Outcomes Research and Policies

Ruixue Liu
Chunxiao Liu
Di Hu
Longkun Wang
Dianwei Feng
Tongxin Guo
Ying Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1501701

519 views

Technology and Code

Published on 26 Mar 2025

Integrating WHO’s digital adaptation kit for antenatal care into BornFyne-PNMS: insights from Cameroon

in Drugs Outcomes Research and Policies

Miriam Nkangu
Brice Tangang
Arthur Pessa
Donald Weledji
Pamela Obegu
Mwenya Kasonde
Ngo V. Ngo
Franck Wanda
Ronald M. Gobina
Odette Kibu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1474999

381 views

Original Research

Published on 26 Mar 2025

Reform progress and achievements of China’s incentive policies for pediatric medicine over the last decade

in Drugs Outcomes Research and Policies

Qiwei Wang
Xing Ling
Zhengli Dai
Xiaoling Wang
Wen Guo
Guiliang Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1561095

254 views

Brief Research Report

Published on 25 Mar 2025

Use of Bayesian approaches in oncology clinical trials: A cross-sectional analysis

in Drugs Outcomes Research and Policies

Borja G. Lopez-Rey
Gerard Carot-Sans
Dan Ouchi
Ferran Torres
Caridad Pontes

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1548997

670 views

Original Research

Accepted on 24 Mar 2025

Statins and long-term risk of revision surgery after total hip arthroplasty in osteoarthritis: a multi-source data linkage study

in Drugs Outcomes Research and Policies

Andrea D'Amuri
Barbara Bordini
Mauro Pagani
Jacopo Ciaffi
Claudio D'Agostino
Alberto Di Martino
Cesare Faldini
Francesco Ursini

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1492200